BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19744266)

  • 21. No association between genetic hemochromatosis and alpha1-antitrypsin deficiency.
    Fargion S; Bissoli F; Fracanzani AL; Suigo E; Sergi C; Taioli E; Ceriani R; Dimasi V; Piperno A; Sampietro M; Fiorelli G
    Hepatology; 1996 Nov; 24(5):1161-4. PubMed ID: 8903392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alpha-1-antitrypsin deficiency and liver diseases].
    Bartók K; Korányi G; Bartók K; Nádor K; Hegedũs C
    Morphol Igazsagugyi Orv Sz; 1989 Oct; 29(4):249-54. PubMed ID: 2594021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary liver cell carcinoma as complication of alpha 1-antitrypsin deficiency in a 67 year old man].
    van den Hazel SJ; Meijer JW; van den Elshout FJ; de Vries RA
    Ned Tijdschr Geneeskd; 2000 Nov; 144(47):2269-72. PubMed ID: 11109473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatocellular carcinoma and the alpha 1-antitrypsin phenotype].
    Labadie H; Sesboué R; Martin JP; Beaugrand M
    Gastroenterol Clin Biol; 1985 Dec; 9(12):881-5. PubMed ID: 3007258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-1-antitrypsin deficiency and liver diseases in Nigeria.
    Olusi SO
    Trop Geogr Med; 1990 Jan; 42(1):41-6. PubMed ID: 2175465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cirrhosis and hepatocellular carcinoma in a patient with heterozygous (MZ) alpha-1-antitrypsin deficiency.
    Marwick TH; Cooney PT; Kerlin P
    Pathology; 1985 Oct; 17(4):649-52. PubMed ID: 3005953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human α1-antitrypsin.
    Baligar P; Kochat V; Arindkar SK; Equbal Z; Mukherjee S; Patel S; Nagarajan P; Mohanty S; Teckman JH; Mukhopadhyay A
    Hepatology; 2017 Apr; 65(4):1319-1335. PubMed ID: 28056498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-1-antitrypsin deficiency.
    Bals R
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):629-33. PubMed ID: 20955965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Liver and hereditary alpha 1-antitrypsin deficiency].
    Feldmann G
    Gastroenterol Clin Biol; 1993; 17(2):83-93. PubMed ID: 8388836
    [No Abstract]   [Full Text] [Related]  

  • 30. Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse?
    Schmechel DE
    Neurotoxicology; 2007 Sep; 28(5):899-914. PubMed ID: 17659342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-1-antitrypsin deficiency and hepatocellular carcinoma. Determination of Pi phenotypes using iso-electric focusing.
    Vergalla J; Jones EA; Kew MC
    S Afr Med J; 1983 Dec; 64(24):950-1. PubMed ID: 6316569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low incidence of alpha 1-antitrypsin deficiency among Filipinos with neonatal cholestatis.
    Tan JJ; Cutiongco-dela Paz EM; Avila JM; Gregorio GV
    J Paediatr Child Health; 2006 Nov; 42(11):694-7. PubMed ID: 17044896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review.
    Kok KF; Wahab PJ; Houwen RH; Drenth JP; de Man RA; van Hoek B; Meijer JW; Willekens FL; de Vries RA
    Neth J Med; 2007 May; 65(5):160-6. PubMed ID: 17519511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
    Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
    Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimal liver disease in young persons with homozygous and heterozygous alpha-1-antitrypsin deficiency.
    Hultcrantz R; Jelf E; Nilsson LH
    Scand J Gastroenterol; 1984 May; 19(3):389-93. PubMed ID: 6610920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periodic acid Schiff-positive non-glycogenic globules in hepatocytes. Differential diagnostic aspects in screening for alpha-1-antitrypsin globules in an autopsy material.
    Reintoft I
    Acta Pathol Microbiol Scand A; 1978 Jul; 86(4):325-9. PubMed ID: 362805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatic involvement in hereditary alpha-1-antitrypsin deficiency].
    Lachaux A; Dumortier J
    Rev Mal Respir; 2014 Apr; 31(4):357-64. PubMed ID: 24750955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1-antitrypsin - a study on 48 pediatric patients.
    Lang T; Mühlbauer M; Strobelt M; Weidinger S; Hadorn HB
    Eur J Med Res; 2005 Dec; 10(12):509-14. PubMed ID: 16356865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor origin of de novo hepatocellular carcinoma in hepatic allografts.
    Flemming P; Tillmann HL; Barg-Hock H; Kleeberger W; Manns MP; Klempnauer J; Kreipe HH
    Transplantation; 2003 Sep; 76(5):871-3. PubMed ID: 14501871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.